+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Colchicine Market - Global Forecast 2026-2032- Product Image
Colchicine Market - Global Forecast 2026-2032- Product Image
New

Colchicine Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 198 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5967649
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The colchicine market is experiencing pivotal transformation as evolving clinical practices, robust supply frameworks, and shifting regulatory requirements redefine priorities for industry leaders, commercial strategists, and healthcare decision-makers. Aligning organizational strategies with these forces is critical in maintaining competitive advantage across global pharmaceutical value chains.

Colchicine Market Snapshot

The colchicine market expanded from USD 1.71 billion in 2025 to USD 1.85 billion in 2026 and is projected to reach USD 2.94 billion by 2032, reflecting a CAGR of 8.08%. This growth is supported by increased integration of colchicine in therapies targeting inflammatory and autoinflammatory conditions. Clinical adoption is driven by novel formulations and stronger commercial models. Industry stakeholders are adapting rapidly to payer and regulatory changes, ensuring sustainable expansion across diverse healthcare environments worldwide.

Scope & Segmentation of the Colchicine Market

This comprehensive evaluation of the colchicine market covers its main clinical use cases, product distinctions, and operational dynamics:

  • Indications: Includes gout, familial Mediterranean fever, pericarditis, and Behçet’s disease, each demanding precise monitoring protocols and tailored treatment approaches.
  • Formulations: Features oral tablets, oral capsules, and injectables, equipped for both short-term and long-term management.
  • Route of Administration: Encompasses oral and parenteral delivery, addressing requirements for ambulatory and hospital-based regimens.
  • Dosage Segmentation: Offers standard, low, and high-dose formats, which influence packaging logistics, prescribing practices, and patient safety frameworks.
  • End-User Settings: Addresses clinics, hospitals, and home care environments, each shaping procurement decisions, patient engagement, and inventory oversight.
  • Distribution Channels: Hospital pharmacy, retail pharmacy, and online pharmacy models provide patients with expanded access options and create varied regulatory checkpoints.
  • Regional Coverage: Analysis encompasses the Americas, Europe, Middle East & Africa, and Asia-Pacific, factoring in distinct clinical protocols and regulatory demands across regions.
  • Technology & Supply Chain: Examines use of supply chain analytics, digital adherence solutions, and evolving formulation sciences, each bolstering the market’s ability to deliver consistent value amid external pressures.

Key Takeaways

  • Colchicine maintains significance in current clinical pathways, supporting therapeutic needs for acute and chronic conditions within the anti-inflammatory landscape.
  • Innovations in patient stratification and advanced formulation technologies enable customized therapies for defined patient populations and care settings.
  • Strategic investments in supply chain infrastructure prioritize redundancy and regional solutions, reducing vulnerabilities from global trade uncertainties.
  • Heightened regulatory expectations drive demand for real-world data and ongoing surveillance, strengthening payer and clinical confidence in product safety and effectiveness.
  • Commercialization adapts to market shifts through broader adoption of digital pharmacies alongside emphasis on home care, enhancing patient reach and supporting adherence efforts.
  • Ongoing collaboration among clinical, procurement, and logistics stakeholders is essential to meet operational challenges and capture growth opportunities.

Tariff Impact on the Colchicine Supply Chain

Revisions to US tariff policies have introduced additional complexity into colchicine procurement and distribution. Manufacturers are reevaluating sourcing strategies and supply chain models to manage ingredient and packaging costs, prompting exploration of regional production and nearshoring. Health systems and procurement specialists are recalibrating supplier contracts to maintain continuity and manage emerging acquisition costs. As a result, there is increased focus on transparent pricing structures and cooperative cost strategies from manufacturers to end users.

Methodology & Data Sources

This analysis applies a mixed-methods framework, incorporating primary expert interviews, regulatory documentation, supply chain mapping, and systematic secondary research. All findings are validated by triangulation, including scenario assessments to gauge the effects of regulatory, manufacturing, and distribution channel changes. Stakeholder perspectives and operational case studies further refine actionable recommendations.

Why This Report Matters

  • Presents actionable market intelligence aligned with strategic priorities for commercial, clinical, and supply chain leaders.
  • Highlights evolving patterns in clinical use, patient-centric delivery, and market access that inform competitive positioning and risk mitigation.
  • Supports manufacturers and healthcare providers in optimizing planning for future growth and ensuring resilient supply operations.

Conclusion

As market conditions, regulatory requirements, and supply logistics continue to shift, a unified approach that couples operational resilience with evidence-driven strategies will prove essential. Organizations capable of rapid adaptation are likely to achieve sustained market presence and fulfill stakeholder objectives.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Colchicine Market, by Indication
8.1. Behçet’s Disease
8.2. Familial Mediterranean Fever
8.3. Gout
8.4. Pericarditis
9. Colchicine Market, by Formulation
9.1. Injectable
9.1.1. Intramuscular
9.1.2. Intravenous
9.2. Oral Capsule
9.3. Oral Tablet
9.3.1. Extended Release
9.3.2. Standard Release
10. Colchicine Market, by Route
10.1. Oral
10.2. Parenteral
10.2.1. Intramuscular
10.2.2. Intravenous
11. Colchicine Market, by Dosage
11.1. High Dose
11.1.1. 1.8 mg
11.1.2. 2.4 mg
11.2. Low Dose
11.2.1. 0.3 mg
11.2.2. 0.6 mg
11.3. Standard Dose
12. Colchicine Market, by End User
12.1. Clinics
12.2. Home Care Settings
12.3. Hospitals
13. Colchicine Market, by Distribution Channel
13.1. Hospital Pharmacy
13.2. Online Pharmacy
13.2.1. Direct-to-Consumer
13.2.2. Partner Platforms
13.3. Retail Pharmacy
13.3.1. Chain
13.3.2. Independent
14. Colchicine Market, by Region
14.1. Americas
14.1.1. North America
14.1.2. Latin America
14.2. Europe, Middle East & Africa
14.2.1. Europe
14.2.2. Middle East
14.2.3. Africa
14.3. Asia-Pacific
15. Colchicine Market, by Group
15.1. ASEAN
15.2. GCC
15.3. European Union
15.4. BRICS
15.5. G7
15.6. NATO
16. Colchicine Market, by Country
16.1. United States
16.2. Canada
16.3. Mexico
16.4. Brazil
16.5. United Kingdom
16.6. Germany
16.7. France
16.8. Russia
16.9. Italy
16.10. Spain
16.11. China
16.12. India
16.13. Japan
16.14. Australia
16.15. South Korea
17. United States Colchicine Market
18. China Colchicine Market
19. Competitive Landscape
19.1. Market Concentration Analysis, 2025
19.1.1. Concentration Ratio (CR)
19.1.2. Herfindahl Hirschman Index (HHI)
19.2. Recent Developments & Impact Analysis, 2025
19.3. Product Portfolio Analysis, 2025
19.4. Benchmarking Analysis, 2025
19.5. AGEPHA Pharma USA, LLC
19.6. Alchem International Pvt Ltd
19.7. Ascend Laboratories, LLC
19.8. Aurobindo Pharma Limited
19.9. Bio-Techne Corporation
19.10. bioWORLD by GeneLinx International, Inc.
19.11. Camber Pharmaceuticals, Inc.
19.12. Dr. Reddy’s Laboratories Ltd.
19.13. Endo International PLC
19.14. EURO-PHARM International Canada Inc.
19.15. Hefei Home Sunshine Pharmaceutical Technology Co., Ltd.
19.16. Hikma Pharmaceuticals
19.17. Indena S.p.A.
19.18. LGM Pharma
19.19. Odan Laboratories Ltd
19.20. Pfizer Inc.
19.21. Takeda Pharmaceutical Company Limited
19.22. Teva Pharmaceutical Industries Ltd.
19.23. Vital Laboratories Private Limited
List of Figures
FIGURE 1. GLOBAL COLCHICINE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL COLCHICINE MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL COLCHICINE MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL COLCHICINE MARKET SIZE, BY INDICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL COLCHICINE MARKET SIZE, BY FORMULATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL COLCHICINE MARKET SIZE, BY ROUTE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL COLCHICINE MARKET SIZE, BY DOSAGE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL COLCHICINE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL COLCHICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL COLCHICINE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL COLCHICINE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL COLCHICINE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 13. UNITED STATES COLCHICINE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 14. CHINA COLCHICINE MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL COLCHICINE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL COLCHICINE MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL COLCHICINE MARKET SIZE, BY BEHÇET’S DISEASE, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL COLCHICINE MARKET SIZE, BY BEHÇET’S DISEASE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL COLCHICINE MARKET SIZE, BY BEHÇET’S DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL COLCHICINE MARKET SIZE, BY FAMILIAL MEDITERRANEAN FEVER, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL COLCHICINE MARKET SIZE, BY FAMILIAL MEDITERRANEAN FEVER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL COLCHICINE MARKET SIZE, BY FAMILIAL MEDITERRANEAN FEVER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL COLCHICINE MARKET SIZE, BY GOUT, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL COLCHICINE MARKET SIZE, BY GOUT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL COLCHICINE MARKET SIZE, BY GOUT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL COLCHICINE MARKET SIZE, BY PERICARDITIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL COLCHICINE MARKET SIZE, BY PERICARDITIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL COLCHICINE MARKET SIZE, BY PERICARDITIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL COLCHICINE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL COLCHICINE MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL COLCHICINE MARKET SIZE, BY INJECTABLE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL COLCHICINE MARKET SIZE, BY INJECTABLE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL COLCHICINE MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL COLCHICINE MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL COLCHICINE MARKET SIZE, BY INTRAMUSCULAR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL COLCHICINE MARKET SIZE, BY INTRAMUSCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL COLCHICINE MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL COLCHICINE MARKET SIZE, BY INTRAVENOUS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL COLCHICINE MARKET SIZE, BY INTRAVENOUS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL COLCHICINE MARKET SIZE, BY ORAL CAPSULE, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL COLCHICINE MARKET SIZE, BY ORAL CAPSULE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL COLCHICINE MARKET SIZE, BY ORAL CAPSULE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL COLCHICINE MARKET SIZE, BY ORAL TABLET, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL COLCHICINE MARKET SIZE, BY ORAL TABLET, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL COLCHICINE MARKET SIZE, BY ORAL TABLET, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL COLCHICINE MARKET SIZE, BY ORAL TABLET, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL COLCHICINE MARKET SIZE, BY EXTENDED RELEASE, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL COLCHICINE MARKET SIZE, BY EXTENDED RELEASE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL COLCHICINE MARKET SIZE, BY EXTENDED RELEASE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL COLCHICINE MARKET SIZE, BY STANDARD RELEASE, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL COLCHICINE MARKET SIZE, BY STANDARD RELEASE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL COLCHICINE MARKET SIZE, BY STANDARD RELEASE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL COLCHICINE MARKET SIZE, BY ROUTE, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL COLCHICINE MARKET SIZE, BY ORAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL COLCHICINE MARKET SIZE, BY ORAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL COLCHICINE MARKET SIZE, BY ORAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL COLCHICINE MARKET SIZE, BY PARENTERAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL COLCHICINE MARKET SIZE, BY PARENTERAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL COLCHICINE MARKET SIZE, BY PARENTERAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL COLCHICINE MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL COLCHICINE MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL COLCHICINE MARKET SIZE, BY INTRAMUSCULAR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL COLCHICINE MARKET SIZE, BY INTRAMUSCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL COLCHICINE MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL COLCHICINE MARKET SIZE, BY INTRAVENOUS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL COLCHICINE MARKET SIZE, BY INTRAVENOUS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL COLCHICINE MARKET SIZE, BY DOSAGE, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL COLCHICINE MARKET SIZE, BY HIGH DOSE, BY REGION, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL COLCHICINE MARKET SIZE, BY HIGH DOSE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL COLCHICINE MARKET SIZE, BY HIGH DOSE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL COLCHICINE MARKET SIZE, BY HIGH DOSE, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL COLCHICINE MARKET SIZE, BY 1.8 MG, BY REGION, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL COLCHICINE MARKET SIZE, BY 1.8 MG, BY GROUP, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL COLCHICINE MARKET SIZE, BY 1.8 MG, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL COLCHICINE MARKET SIZE, BY 2.4 MG, BY REGION, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL COLCHICINE MARKET SIZE, BY 2.4 MG, BY GROUP, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL COLCHICINE MARKET SIZE, BY 2.4 MG, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL COLCHICINE MARKET SIZE, BY LOW DOSE, BY REGION, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL COLCHICINE MARKET SIZE, BY LOW DOSE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL COLCHICINE MARKET SIZE, BY LOW DOSE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL COLCHICINE MARKET SIZE, BY LOW DOSE, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL COLCHICINE MARKET SIZE, BY 0.3 MG, BY REGION, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL COLCHICINE MARKET SIZE, BY 0.3 MG, BY GROUP, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL COLCHICINE MARKET SIZE, BY 0.3 MG, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL COLCHICINE MARKET SIZE, BY 0.6 MG, BY REGION, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL COLCHICINE MARKET SIZE, BY 0.6 MG, BY GROUP, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL COLCHICINE MARKET SIZE, BY 0.6 MG, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL COLCHICINE MARKET SIZE, BY STANDARD DOSE, BY REGION, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL COLCHICINE MARKET SIZE, BY STANDARD DOSE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL COLCHICINE MARKET SIZE, BY STANDARD DOSE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL COLCHICINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL COLCHICINE MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL COLCHICINE MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL COLCHICINE MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL COLCHICINE MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL COLCHICINE MARKET SIZE, BY HOME CARE SETTINGS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL COLCHICINE MARKET SIZE, BY HOME CARE SETTINGS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL COLCHICINE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL COLCHICINE MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL COLCHICINE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL COLCHICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL COLCHICINE MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL COLCHICINE MARKET SIZE, BY HOSPITAL PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL COLCHICINE MARKET SIZE, BY HOSPITAL PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL COLCHICINE MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL COLCHICINE MARKET SIZE, BY ONLINE PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL COLCHICINE MARKET SIZE, BY ONLINE PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL COLCHICINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL COLCHICINE MARKET SIZE, BY DIRECT-TO-CONSUMER, BY REGION, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL COLCHICINE MARKET SIZE, BY DIRECT-TO-CONSUMER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL COLCHICINE MARKET SIZE, BY DIRECT-TO-CONSUMER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL COLCHICINE MARKET SIZE, BY PARTNER PLATFORMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL COLCHICINE MARKET SIZE, BY PARTNER PLATFORMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL COLCHICINE MARKET SIZE, BY PARTNER PLATFORMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL COLCHICINE MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL COLCHICINE MARKET SIZE, BY RETAIL PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL COLCHICINE MARKET SIZE, BY RETAIL PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL COLCHICINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL COLCHICINE MARKET SIZE, BY CHAIN, BY REGION, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL COLCHICINE MARKET SIZE, BY CHAIN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL COLCHICINE MARKET SIZE, BY CHAIN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL COLCHICINE MARKET SIZE, BY INDEPENDENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL COLCHICINE MARKET SIZE, BY INDEPENDENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL COLCHICINE MARKET SIZE, BY INDEPENDENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL COLCHICINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 112. AMERICAS COLCHICINE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 113. AMERICAS COLCHICINE MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 114. AMERICAS COLCHICINE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 115. AMERICAS COLCHICINE MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 116. AMERICAS COLCHICINE MARKET SIZE, BY ORAL TABLET, 2018-2032 (USD MILLION)
TABLE 117. AMERICAS COLCHICINE MARKET SIZE, BY ROUTE, 2018-2032 (USD MILLION)
TABLE 118. AMERICAS COLCHICINE MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
TABLE 119. AMERICAS COLCHICINE MARKET SIZE, BY DOSAGE, 2018-2032 (USD MILLION)
TABLE 120. AMERICAS COLCHICINE MARKET SIZE, BY HIGH DOSE, 2018-2032 (USD MILLION)
TABLE 121. AMERICAS COLCHICINE MARKET SIZE, BY LOW DOSE, 2018-2032 (USD MILLION)
TABLE 122. AMERICAS COLCHICINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 123. AMERICAS COLCHICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 124. AMERICAS COLCHICINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 125. AMERICAS COLCHICINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
TABLE 126. NORTH AMERICA COLCHICINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 127. NORTH AMERICA COLCHICINE MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 128. NORTH AMERICA COLCHICINE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 129. NORTH AMERICA COLCHICINE MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 130. NORTH AMERICA COLCHICINE MARKET SIZE, BY ORAL TABLET, 2018-2032 (USD MILLION)
TABLE 131. NORTH AMERICA COLCHICINE MARKET SIZE, BY ROUTE, 2018-2032 (USD MILLION)
TABLE 132. NORTH AMERICA COLCHICINE MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
TABLE 133. NORTH AMERICA COLCHICINE MARKET SIZE, BY DOSAGE, 2018-2032 (USD MILLION)
TABLE 134. NORTH AMERICA COLCHICINE MARKET SIZE, BY HIGH DOSE, 2018-2032 (USD MILLION)
TABLE 135. NORTH AMERICA COLCHICINE MARKET SIZE, BY LOW DOSE, 2018-2032 (USD MILLION)
TABLE 136. NORTH AMERICA COLCHICINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 137. NORTH AMERICA COLCHICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 138. NORTH AMERICA COLCHICINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 139. NORTH AMERICA COLCHICINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
TABLE 140. LATIN AMERICA COLCHICINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 141. LATIN AMERICA COLCHICINE MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 142. LATIN AMERICA COLCHICINE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 143. LATIN AMERICA COLCHICINE MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 144. LATIN AMERICA COLCHICINE MARKET SIZE, BY ORAL TABLET, 2018-2032 (USD MILLION)
TABLE 145. LATIN AMERICA COLCHICINE MARKET SIZE, BY ROUTE, 2018-2032 (USD MILLION)
TABLE 146. LATIN AMERICA COLCHICINE MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
TABLE 147. LATIN AMERICA COLCHICINE MARKET SIZE, BY DOSAGE, 2018-2032 (USD MILLION)
TABLE 148. LATIN AMERICA COLCHICINE MARKET SIZE, BY HIGH DOSE, 2018-2032 (USD MILLION)
TABLE 149. LATIN AMERICA COLCHICINE MARKET SIZE, BY LOW DOSE, 2018-2032 (USD MILLION)
TABLE 150. LATIN AMERICA COLCHICINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 151. LATIN AMERICA COLCHICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 152. LATIN AMERICA COLCHICINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 153. LATIN AMERICA COLCHICINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA COLCHICINE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA COLCHICINE MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA COLCHICINE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA COLCHICINE MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA COLCHICINE MARKET SIZE, BY ORAL TABLET, 2018-2032 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA COLCHICINE MARKET SIZE, BY ROUTE, 2018-2032 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA COLCHICINE MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA COLCHICINE MARKET SIZE, BY DOSAGE, 2018-2032 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA COLCHICINE MARKET SIZE, BY HIGH DOSE, 2018-2032 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA COLCHICINE MARKET SIZE, BY LOW DOSE, 2018-2032 (USD MILLION)
TABLE 164. EUROPE, MIDDLE EAST & AFRICA COLCHICINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 165. EUROPE, MIDDLE EAST & AFRICA COLCHICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 166. EUROPE, MIDDLE EAST & AFRICA COLCHICINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 167. EUROPE, MIDDLE EAST & AFRICA COLCHICINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
TABLE 168. EUROPE COLCHICINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 169. EUROPE COLCHICINE MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 170. EUROPE COLCHICINE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 171. EUROPE COLCHICINE MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 172. EUROPE COLCHICINE MARKET SIZE, BY ORAL TABLET, 2018-2032 (USD MILLION)
TABLE 173. EUROPE COLCHICINE MARKET SIZE, BY ROUTE, 2018-2032 (USD MILLION)
TABLE 174. EUROPE COLCHICINE MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
TABLE 175. EUROPE COLCHICINE MARKET SIZE, BY DOSAGE, 2018-2032 (USD MILLION)
TABLE 176. EUROPE COLCHICINE MARKET SIZE, BY HIGH DOSE, 2018-2032 (USD MILLION)
TABLE 177. EUROPE COLCHICINE MARKET SIZE, BY LOW DOSE, 2018-2032 (USD MILLION)
TABLE 178. EUROPE COLCHICINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 179. EUROPE COLCHICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 180. EUROPE COLCHICINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 181. EUROPE COLCHICINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
TABLE 182. MIDDLE EAST COLCHICINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 183. MIDDLE EAST COLCHICINE MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 184. MIDDLE EAST COLCHICINE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 185. MIDDLE EAST COLCHICINE MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 186. MIDDLE EAST COLCHICINE MARKET SIZE, BY ORAL TABLET, 2018-2032 (USD MILLION)
TABLE 187. MIDDLE EAST COLCHICINE MARKET SIZE, BY ROUTE, 2018-2032 (USD MILLION)
TABLE 188. MIDDLE EAST COLCHICINE MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
TABLE 189. MIDDLE EAST COLCHICINE MARKET SIZE, BY DOSAGE, 2018-2032 (USD MILLION)
TABLE 190. MIDDLE EAST COLCHICINE MARKET SIZE, BY HIGH DOSE, 2018-2032 (USD MILLION)
TABLE 191. MIDDLE EAST COLCHICINE MARKET SIZE, BY LOW DOSE, 2018-2032 (USD MILLION)
TABLE 192. MIDDLE EAST COLCHICINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 193. MIDDLE EAST COLCHICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 194. MIDDLE EAST COLCHICINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 195. MIDDLE EAST COLCHICINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
TABLE 196. AFRICA COLCHICINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 197. AFRICA COLCHICINE MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 198. AFRICA COLCHICINE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 199. AFRICA COLCHICINE MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 200. AFRICA COLCHICINE MARKET SIZE, BY ORAL TABLET, 2018-2032 (USD MILLION)
TABLE 201. AFRICA COLCHICINE MARKET SIZE, BY ROUTE, 2018-2032 (USD MILLION)
TABLE 202. AFRICA COLCHICINE MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
TABLE 203. AFRICA COLCHICINE MARKET SIZE, BY DOSAGE, 2018-2032 (USD MILLION)
TABLE 204. AFRICA COLCHICINE MARKET SIZE, BY HIGH DOSE, 2018-2032 (USD MILLION)
TABLE 205. AFRICA COLCHICINE MARKET SIZE, BY LOW DOSE, 2018-2032 (USD MILLION)
TABLE 206. AFRICA COLCHICINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 207. AFRICA COLCHICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 208. AFRICA COLCHICINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 209. AFRICA COLCHICINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
TABLE 210. ASIA-PACIFIC COLCHICINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 211. ASIA-PACIFIC COLCHICINE MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 212. ASIA-PACIFIC COLCHICINE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 213. ASIA-PACIFIC COLCHICINE MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 214. ASIA-PACIFIC COLCHICINE MARKET SIZE, BY ORAL TABLET, 2018-2032 (USD MILLION)
TABLE 215. ASIA-PACIFIC COLCHICINE MARKET SIZE, BY ROUTE, 2018-2032 (USD MILLION)
TABLE 216. ASIA-PACIFIC COLCHICINE MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
TABLE 217. ASIA-PACIFIC COLCHICINE MARKET SIZE, BY DOSAGE, 2018-2032 (USD MILLION)
TABLE 218. ASIA-PACIFIC COLCHICINE MARKET SIZE, BY HIGH DOSE, 2018-2032 (USD MILLION)
TABLE 219. ASIA-PACIFIC COLCHICINE MARKET SIZE, BY LOW DOSE, 2018-2032 (USD MILLION)
TABLE 220. ASIA-PACIFIC COLCHICINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 221. ASIA-PACIFIC COLCHICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 222. ASIA-PACIFIC COLCHICINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 223. ASIA-PACIFIC COLCHICINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
TABLE 224. GLOBAL COLCHICINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 225. ASEAN COLCHICINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 226. ASEAN COLCHICINE MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 227. ASEAN COLCHICINE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 228. ASEAN COLCHICINE MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 229. ASEAN COLCHICINE MARKET SIZE, BY ORAL TABLET, 2018-2032 (USD MILLION)
TABLE 230. ASEAN COLCHICINE MARKET SIZE, BY ROUTE, 2018-2032 (USD MILLION)
TABLE 231. ASEAN COLCHICINE MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
TABLE 232. ASEAN COLCHICINE MARKET SIZE, BY DOSAGE, 2018-2032 (USD MILLION)
TABLE 233. ASEAN COLCHICINE MARKET SIZE, BY HIGH DOSE, 2018-2032 (USD MILLION)
TABLE 234. ASEAN COLCHICINE MARKET SIZE, BY LOW DOSE, 2018-2032 (USD MILLION)
TABLE 235. ASEAN COLCHICINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 236. ASEAN COLCHICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 237. ASEAN COLCHICINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 238. ASEAN COLCHICINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
TABLE 239. GCC COLCHICINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 240. GCC COLCHICINE MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 241. GCC COLCHICINE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 242. GCC COLCHICINE MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 243. GCC COLCHICINE MARKET SIZE, BY ORAL TABLET, 2018-2032 (USD MILLION)
TABLE 244. GCC COLCHICINE MARKET SIZE, BY ROUTE, 2018-2032 (USD MILLION)
TABLE 245. GCC COLCHICINE MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
TABLE 246. GCC COLCHICINE MARKET SIZE, BY DOSAGE, 2018-2032 (USD MILLION)
TABLE 247. GCC COLCHICINE MARKET SIZE, BY HIGH DOSE, 2018-2032 (USD MILLION)
TABLE 248. GCC COLCHICINE MARKET SIZE, BY LOW DOSE, 2018-2032 (USD MILLION)
TABLE 249. GCC COLCHICINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 250. GCC COLCHICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 251. GCC COLCHICINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 252. GCC COLCHICINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
TABLE 253. EUROPEAN UNION COLCHICINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 254. EUROPEAN UNION COLCHICINE MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 255. EUROPEAN UNION COLCHICINE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 256. EUROPEAN UNION COLCHICINE MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 257. EUROPEAN UNION COLCHICINE MARKET SIZE, BY ORAL TABLET, 2018-2032 (USD MILLION)
TABLE 258. EUROPEAN UNION COLCHICINE MARKET SIZE, BY ROUTE, 2018-2032 (USD MILLION)
TABLE 259. EUROPEAN UNION COLCHICINE MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
TABLE 260. EUROPEAN UNION COLCHICINE MARKET SIZE, BY DOSAGE, 2018-2032 (USD MILLION)
TABLE 261. EUROPEAN UNION COLCHICINE MARKET SIZE, BY HIGH DOSE, 2018-2032 (USD MILLION)
TABLE 262. EUROPEAN UNION COLCHICINE MARKET SIZE, BY LOW DOSE, 2018-2032 (USD MILLION)
TABLE 263. EUROPEAN UNION COLCHICINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 264. EUROPEAN UNION COLCHICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 265. EUROPEAN UNION COLCHICINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 266. EUROPEAN UNION COLCHICINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
TABLE 267. BRICS COLCHICINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 268. BRICS COLCHICINE MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 269. BRICS COLCHICINE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 270. BRICS COLCHICINE MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 271. BRICS COLCHICINE MARKET SIZE, BY ORAL TABLET, 2018-2032 (USD MILLION)
TABLE 272. BRICS COLCHICINE MARKET SIZE, BY ROUTE, 2018-2032 (USD MILLION)
TABLE 273. BRICS COLCHICINE MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
TABLE 274. BRICS COLCHICINE MARKET SIZE, BY DOSAGE, 2018-2032 (USD MILLION)
TABLE 275. BRICS COLCHICINE MARKET SIZE, BY HIGH DOSE, 2018-2032 (USD MILLION)
TABLE 276. BRICS COLCHICINE MARKET SIZE, BY LOW DOSE, 2018-2032 (USD MILLION)
TABLE 277. BRICS COLCHICINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 278. BRICS COLCHICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 279. BRICS COLCHICINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 280. BRICS COLCHICINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
TABLE 281. G7 COLCHICINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 282. G7 COLCHICINE MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 283. G7 COLCHICINE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 284. G7 COLCHICINE MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 285. G7 COLCHICINE MARKET SIZE, BY ORAL TABLET, 2018-2032 (USD MILLION)
TABLE 286. G7 COLCHICINE MARKET SIZE, BY ROUTE, 2018-2032 (USD MILLION)
TABLE 287. G7 COLCHICINE MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
TABLE 288. G7 COLCHICINE MARKET SIZE, BY DOSAGE, 2018-2032 (USD MILLION)
TABLE 289. G7 COLCHICINE MARKET SIZE, BY HIGH DOSE, 2018-2032 (USD MILLION)
TABLE 290. G7 COLCHICINE MARKET SIZE, BY LOW DOSE, 2018-2032 (USD MILLION)
TABLE 291. G7 COLCHICINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 292. G7 COLCHICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 293. G7 COLCHICINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 294. G7 COLCHICINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
TABLE 295. NATO COLCHICINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 296. NATO COLCHICINE MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 297. NATO COLCHICINE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 298. NATO COLCHICINE MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 299. NATO COLCHICINE MARKET SIZE, BY ORAL TABLET, 2018-2032 (USD MILLION)
TABLE 300. NATO COLCHICINE MARKET SIZE, BY ROUTE, 2018-2032 (USD MILLION)
TABLE 301. NATO COLCHICINE MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
TABLE 302. NATO COLCHICINE MARKET SIZE, BY DOSAGE, 2018-2032 (USD MILLION)
TABLE 303. NATO COLCHICINE MARKET SIZE, BY HIGH DOSE, 2018-2032 (USD MILLION)
TABLE 304. NATO COLCHICINE MARKET SIZE, BY LOW DOSE, 2018-2032 (USD MILLION)
TABLE 305. NATO COLCHICINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 306. NATO COLCHICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 307. NATO COLCHICINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 308. NATO COLCHICINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
TABLE 309. GLOBAL COLCHICINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 310. UNITED STATES COLCHICINE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 311. UNITED STATES COLCHICINE MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 312. UNITED STATES COLCHICINE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 313. UNITED STATES COLCHICINE MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 314. UNITED STATES COLCHICINE MARKET SIZE, BY ORAL TABLET, 2018-2032 (USD MILLION)
TABLE 315. UNITED STATES COLCHICINE MARKET SIZE, BY ROUTE, 2018-2032 (USD MILLION)
TABLE 316. UNITED STATES COLCHICINE MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
TABLE 317. UNITED STATES COLCHICINE MARKET SIZE, BY DOSAGE, 2018-2032 (USD MILLION)
TABLE 318. UNITED STATES COLCHICINE MARKET SIZE, BY HIGH DOSE, 2018-2032 (USD MILLION)
TABLE 319. UNITED STATES COLCHICINE MARKET SIZE, BY LOW DOSE, 2018-2032 (USD MILLION)
TABLE 320. UNITED STATES COLCHICINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 321. UNITED STATES COLCHICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 322. UNITED STATES COLCHICINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 323. UNITED STATES COLCHICINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
TABLE 324. CHINA COLCHICINE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 325. CHINA COLCHICINE MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 326. CHINA COLCHICINE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 327. CHINA COLCHICINE MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 328. CHINA COLCHICINE MARKET SIZE, BY ORAL TABLET, 2018-2032 (USD MILLION)
TABLE 329. CHINA COLCHICINE MARKET SIZE, BY ROUTE, 2018-2032 (USD MILLION)
TABLE 330. CHINA COLCHICINE MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
TABLE 331. CHINA COLCHICINE MARKET SIZE, BY DOSAGE, 2018-2032 (USD MILLION)
TABLE 332. CHINA COLCHICINE MARKET SIZE, BY HIGH DOSE, 2018-2032 (USD MILLION)
TABLE 333. CHINA COLCHICINE MARKET SIZE, BY LOW DOSE, 2018-2032 (USD MILLION)
TABLE 334. CHINA COLCHICINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 335. CHINA COLCHICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 336. CHINA COLCHICINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 337. CHINA COLCHICINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Colchicine market report include:
  • AGEPHA Pharma USA, LLC
  • Alchem International Pvt Ltd
  • Ascend Laboratories, LLC
  • Aurobindo Pharma Limited
  • Bio-Techne Corporation
  • bioWORLD by GeneLinx International, Inc.
  • Camber Pharmaceuticals, Inc.
  • Dr. Reddy’s Laboratories Ltd.
  • Endo International PLC
  • EURO-PHARM International Canada Inc.
  • Hefei Home Sunshine Pharmaceutical Technology Co., Ltd.
  • Hikma Pharmaceuticals
  • Indena S.p.A.
  • LGM Pharma
  • Odan Laboratories Ltd
  • Pfizer Inc.
  • Takeda Pharmaceutical Company Limited
  • Teva Pharmaceutical Industries Ltd.
  • Vital Laboratories Private Limited

Table Information

Report AttributeDetails
No. of Pages198
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 1.85 Billion
Forecasted Market Value ( USD ) by 2032 $ 2.94 Billion
Compound Annual Growth Rate8.0%
Regions CoveredGlobal
No. of Companies Mentioned20

Related Topics

Related Reports

Colchicine Tablets Market - Global Forecast 2025-2030 - Product Image

Colchicine Tablets Market - Global Forecast 2025-2030

  • Report
  • 182 Pages
  • Global
From
2025 Colchicine Market Outlook Report: Industry Size, Market Shares Data, Insights, Growth Trends, Opportunities, Competition 2024 to 2032 - Product Image

2025 Colchicine Market Outlook Report: Industry Size, Market Shares Data, Insights, Growth Trends, Opportunities, Competition 2024 to 2032

  • Report
  • 144 Pages
  • Global
From
Colchicine (CAS 64-86-8) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029 - Product Image

Colchicine (CAS 64-86-8) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029

  • Report
  • 50 Pages
  • Global
From
Colchicine Salicylate (CAS 8013-62-5) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029 - Product Image

Colchicine Salicylate (CAS 8013-62-5) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029

  • Report
  • 50 Pages
  • Global
From
Pericarditis Drugs - Global Strategic Business Report - Product Image

Pericarditis Drugs - Global Strategic Business Report

  • Report
  • 289 Pages
  • Global
From

About the Colchicine Market

Colchicine is a medication used to treat and prevent gout and other inflammatory conditions. It is a member of the cardiovascular drug class, which includes drugs used to treat and prevent heart and blood vessel diseases. Colchicine works by reducing inflammation and swelling, and is often used to treat acute gout attacks. It is also used to treat familial Mediterranean fever, pericarditis, and Behcet's disease. Colchicine is available in both oral and injectable forms, and is typically taken once or twice a day. Common side effects include nausea, vomiting, and diarrhea. Serious side effects include liver damage, kidney failure, and bone marrow suppression. The colchicine market is highly competitive, with many generic and branded products available. Companies in the market include Mylan, Teva Pharmaceuticals, Sandoz, and Sun Pharmaceuticals. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.